Maturation Matters: Importance of Maturation for Antitumor Immunity of Dendritic Cell Vaccines
- 15 September 2004
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 22 (18) , 3834-3835
- https://doi.org/10.1200/jco.2004.99.019
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Injection of Immature Dendritic Cells into Adjuvant-Treated Skin Obviates the Need for Ex Vivo MaturationThe Journal of Immunology, 2003
- Clinical and Immunologic Results of a Randomized Phase II Trial of Vaccination Using Four Melanoma Peptides Either Administered in Granulocyte-Macrophage Colony-Stimulating Factor in Adjuvant or Pulsed on Dendritic CellsJournal of Clinical Oncology, 2003
- Optimizing dendritic cell?based anticancer immunotherapy: maturation state does have clinical impactCancer Immunology, Immunotherapy, 2003
- A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injectionInternational Journal of Cancer, 2001
- Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic CellsThe Journal of Experimental Medicine, 2001